• 1. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 2. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 3. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Research Briefing on 2-Formamido-5-methylhexanoic Acid (CAS: 1404825-23-5) in Chemical Biology and Pharmaceutical Applications

2-Formamido-5-methylhexanoic acid (CAS: 1404825-23-5) is a specialized amino acid derivative that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its unique structural features, has been explored for its role in peptide synthesis, drug design, and as a building block for novel therapeutic agents. The presence of both formamido and methylhexanoic acid moieties offers distinct chemical properties that make it a valuable candidate for various biomedical applications.

Recent studies have focused on the synthesis and optimization of 2-formamido-5-methylhexanoic acid to enhance its bioavailability and stability. Researchers have employed advanced techniques such as solid-phase peptide synthesis (SPPS) and microwave-assisted organic synthesis (MAOS) to achieve high yields and purity. These methodologies have been critical in scaling up production for preclinical and clinical studies, ensuring that the compound meets the stringent requirements for pharmaceutical use.

One of the most promising applications of 2-formamido-5-methylhexanoic acid is its incorporation into peptide-based therapeutics. Its structural versatility allows it to serve as a key intermediate in the development of peptide drugs targeting various diseases, including cancer, metabolic disorders, and infectious diseases. For instance, recent preclinical studies have demonstrated its efficacy in enhancing the stability and pharmacokinetic properties of peptide analogs, thereby improving their therapeutic potential.

In addition to its role in peptide therapeutics, 2-formamido-5-methylhexanoic acid has also been investigated for its potential as a modulator of enzymatic activity. Preliminary findings suggest that this compound can interact with specific enzymes involved in metabolic pathways, offering a novel approach to drug discovery. Researchers are particularly interested in its ability to inhibit or activate enzymes that play a critical role in disease progression, such as those involved in inflammation and oxidative stress.

The safety and toxicological profile of 2-formamido-5-methylhexanoic acid have also been a focus of recent research. In vitro and in vivo studies have shown that the compound exhibits low cytotoxicity and favorable biocompatibility, making it a suitable candidate for further development. However, comprehensive toxicological assessments are still underway to ensure its suitability for human use, particularly in long-term therapeutic applications.

Looking ahead, the potential of 2-formamido-5-methylhexanoic acid in personalized medicine and targeted drug delivery systems is an area of active exploration. Advances in nanotechnology and biomaterials have opened new avenues for incorporating this compound into smart drug delivery platforms, enabling precise targeting and controlled release of therapeutic agents. Such innovations could significantly enhance the efficacy and safety of treatments for complex diseases.

In conclusion, 2-formamido-5-methylhexanoic acid (CAS: 1404825-23-5) represents a promising compound with diverse applications in chemical biology and pharmaceutical research. Its unique structural properties, combined with its demonstrated biocompatibility and therapeutic potential, make it a valuable asset in the development of next-generation drugs. Continued research and collaboration across disciplines will be essential to fully unlock its potential and translate these findings into clinical applications.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)